Kai Schumacher

Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study

Gaetano Maria De Ferrari, Lars S. Maier, Peter J. Schwartz et al. · Heart Rhythm · 2015 · 84 citations · Full text

Cardiovascular Disease, Medicine, Cardiovascular Pharmacology +8

The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS

Jan Tack, Kai Schumacher, Giuseppe Tonini et al. · Gut · 2016 · 52 citations

Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial

Arne W. Scholtz, Aleš Hahn, Bohdana Stefflova et al. · Clinical Drug Investigation · 2019 · 41 citations · Full text

Clinical pharmacology of two specific bradycardic agents

H Franke, C. A. P. F. Su, Kai Schumacher et al. · European Heart Journal · 1987 · 22 citations

Thrombosis, Hypertension, Heart Rate +13

Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension

Roberto Fogari, Stefano Taddei, M. Holm‐Bentzen et al. · Clinical Drug Investigation · 2010 · 16 citations

Hypertension, Olmesartan Medoxomil 40, Cardiovascular Disease +8